Definitions of the features selected [50]. by Yu Zhang (12946)

Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

“…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC_{(tofacitinib, 0–∞)} and a 9.61-fold increase of colonic AUC_{(tofacitinib, 0–12h)}, compared with tofacitinib at a molar equivalent oral dose. …”

Viral measurements do not predict off-ART rebound in d4 and d5 ART RMs. by Brandon F. Keele (7450001)

DataSheet_1_Accelerating Decreases in the Incidences of Hepatocellular Carcinoma at a Younger Age in Shanghai Are Associated With Hepatitis B Virus Vaccination.docx by Shunzhang Yu (12340927)

“…HCC incidences in males at younger age groups (age <50 years old), particularly in those with age <34 groups, showed an accelerating decrease over time, whereas HCC incidences significantly declined in the female population across all age groups except for those under 19 years of age. …”

DataSheet_1_Accelerating Decreases in the Incidences of Hepatocellular Carcinoma at a Younger Age in Shanghai Are Associated With Hepatitis B Virus Vaccination.docx by Shunzhang Yu (12340927)

“…HCC incidences in males at younger age groups (age <50 years old), particularly in those with age <34 groups, showed an accelerating decrease over time, whereas HCC incidences significantly declined in the female population across all age groups except for those under 19 years of age. …”

Identification of metabolites with cell type-specific-dynamics reveals the amino acid class as highly conserved in hiPSC and hNSC and that most of the cell type-specific amino acid... by João Vasconcelos e Sá (8721594)

28 days of testosterone depletion decreases fiber CSA only in the TA muscle and only at 1.5-month-old mice. by Arik Davidyan (10450896)

Fig 5 - by Lingru Ruan (18995544)

Average giving in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

Relative fold change (relative to untreated control cells) of the <i>HER-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects:

Relative fold change (relative to untreated control cells) of the <i>PTGS-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects:

Linearity of ACER3 activity assay. by Jae Kyo Yi (13570063)

The kinetics of ACER3 and mutants. by Jae Kyo Yi (13570063)

Comparison between TLC and HPLC used in this study. by Jae Kyo Yi (13570063)

Suggested ACER3 catalytic mechanism. by Jae Kyo Yi (13570063)

HPLC chromatogram of ACER3 reaction. by Jae Kyo Yi (13570063)

The effects of neutral and alkaline ceramidase inhibitors on ACER3 activity. by Jae Kyo Yi (13570063)

HPLC chromatogram of standard NBD-C₁₂-FA. by Jae Kyo Yi (13570063)

Structure of ADPR2 and ACER3. by Jae Kyo Yi (13570063)

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing load for the rectus abdominis muscle. by Christoph Anders (4068499)